Precision NGS panel containing 774 genes designed for oncology and clinical genomics applications. Enables comprehensive genetic profiling for accurate detection of clinically relevant variants in cancer diagnostics.
Manufactured by
Gurugram, Haryana, India
Manufactures molecular diagnostic solutions including next-generation sequencing panels for oncology and clinical genomics, real-time PCR testing kits, and point-of-care molecular diagnostic systems. Specializes in precision NGS panels, validated RT-PCR assays for disease detection including cancer biomarkers and infectious diseases, and nucleic acid extraction kits. Products serve applications in oncology, maternal and child care, infectious disease testing, and personalized medicine diagnostics.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Burning Rock Dx Co. Ltd.
China · 2 relevant products
GENETRON HEALTH (BEIJING) CO., LTD
China · 2 relevant products
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd
China · 1 relevant product
47 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 96 closest product alternatives
Burning Rock Dx Co. Ltd. · China
Next-generation sequencing panel for comprehensive cancer genomic profiling. Identifies mutations, copy number variations, and other genetic alterations to guide personalized treatment strategies.
GENETRON HEALTH (BEIJING) CO., LTD · China
A comprehensive genomic profiling test for tumor patients providing information on 831 cancer-related genes in a single test. The integrated analysis results support precision targeted therapy selection for cancer patients.
Bioscience (Tianjin) DiagnosticTechnology Co.,Ltd · China
Comprehensive multigene panel for hereditary disease identification and cancer risk assessment. Provides clinical-grade analysis with detailed genomic reporting.
93 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products